Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Product revenue, net $ 70,995 $ 63,134
Other revenue 2,674  
Total revenue 73,669 63,134
Operating expenses    
Cost of goods sold - product revenue 30,775 32,084
Research and development 10,943 2,739
Research and development - licenses acquired   13,819
Selling, general and administrative 59,468 39,833
Wire transfer fraud loss   9,540
Total operating expenses 101,186 98,015
Loss from operations (27,517) (34,881)
Other expense (income)    
Interest income (60) (2)
Interest expense 2,019 7,034
Foreign exchange transaction losses 89  
Change in fair value of derivative liability   447
Total other expense (income) 2,048 7,479
Loss before income taxes (29,565) (42,360)
Income tax expense 63 1,634
Net Loss $ (29,628) $ (43,994)
Net loss per common share:    
Basic $ (1.69) $ (4.32)
Diluted $ (1.69) $ (4.32)
Weighted average number of common shares:    
Basic 17,531,274 10,189,844
Diluted 17,531,274 10,189,844